CNMD logo

CONMED (CNMD) Return On Equity

Annual ROE

N/A

December 1, 2024

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

CNMD ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

20.78%
CNMD annual return on equity is currently at an all-time high

3-Year Low

-10.53%
CNMD annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
CNMD previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
CNMD next annual earnings announcement has not yet been scheduled

OtherCNMDprofitabilitymetrics:

Annual Revenue

$1.31 B
CNMD annual revenue is $1.31 billion

Annual Net Income

$132.42 M
CNMD annual net profit is $132.42 million

Annual EPS

$4.25
CNMD annual earnings per share is $4.25

Annual ROA

-
CNMD annual return on assets value is unknown

Quarterly ROE

15.32%
+3.43%+28.85%

September 30, 2024

Summary

Performance

3-Month Change

+28.85%

1-Year Change

+85.7%

3-Year Change

+85.7%

5-Year Change

+85.7%

CNMD Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.27%
CNMD quarterly return on equity is higher than 81.27% of companies in Healthcare sector

High & Low

All-time High

23.08%
CNMD quarterly return on equity is currently -33.62% below its historical high of 23.08%

3-Year Low

-15.20%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CNMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
CNMD next earnings announcement has not yet been scheduled

OtherCNMDprofitabilitymetrics:

Quarterly Revenue

$316.70 M
CNMD quarterly revenue is $316.70 million

Quarterly Net Income

$48.98 M
CNMD quarterly net profit is $48.98 million

Quarterly EPS

$1.57
CNMD quarterly earnings per share is $1.57

Quarterly ROA

5.71%
CNMD quarterly return on assets is 5.71%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-
CNMD annual return on equity value is unknown

Annual Net Income

$132.42 M
CNMD annual net profit is $132.42 million

Annual Shareholders Equity

-
CNMD annual stockholders equity value is unknown

CNMD ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+85.7%
3 y3 years-+85.7%
5 y5 years-+85.7%

CNMD ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+200.8%
5 y5-yearat high+200.8%
alltimeall time-33.6%+200.8%

CONMED ROE History

DateAnnualQuarterly
Sep 2024
-
15.32%(+28.8%)
Jun 2024
-
11.89%(+16.0%)
Mar 2024
-
10.25%(+24.2%)
Dec 2023
8.16%(-177.5%)
8.25%(+7.8%)
Sep 2023
-
7.65%(-36.5%)
Jun 2023
-
12.04%(-194.4%)
Mar 2023
-
-12.75%(+17.4%)
Dec 2022
-10.53%(-225.8%)
-10.86%(-2.3%)
Sep 2022
-
-11.12%(-26.8%)
Jun 2022
-
-15.20%(-270.8%)
Mar 2022
-
8.90%(+5.8%)
Dec 2021
8.37%(+524.6%)
8.41%(-2.2%)
Sep 2021
-
8.60%(+12.4%)
Jun 2021
-
7.65%(+298.4%)
Mar 2021
-
1.92%(+40.1%)
Dec 2020
1.34%(-67.9%)
1.37%(+3325.0%)
Sep 2020
-
0.04%(-33.3%)
Jun 2020
-
0.06%(-98.7%)
Mar 2020
-
4.79%(+16.0%)
Dec 2019
4.17%(-34.0%)
4.13%(-4.2%)
Sep 2019
-
4.31%(+2.6%)
Jun 2019
-
4.20%(-11.2%)
Mar 2019
-
4.73%(-25.0%)
Dec 2018
6.32%(-31.0%)
6.31%(-44.5%)
Sep 2018
-
11.36%(-4.1%)
Jun 2018
-
11.84%(+1.2%)
Mar 2018
-
11.70%(+24.9%)
Dec 2017
9.16%(+263.5%)
9.37%(+252.3%)
Sep 2017
-
2.66%(-1.1%)
Jun 2017
-
2.69%(+26.3%)
Mar 2017
-
2.13%(-15.5%)
Dec 2016
2.52%(-51.8%)
2.52%(-7.4%)
Sep 2016
-
2.72%(-9.0%)
Jun 2016
-
2.99%(-20.9%)
Mar 2016
-
3.78%(-28.3%)
Dec 2015
5.23%(-3.5%)
5.27%(-9.9%)
Sep 2015
-
5.85%(+26.6%)
Jun 2015
-
4.62%(-8.9%)
Mar 2015
-
5.07%(-6.3%)
Dec 2014
5.42%(-8.4%)
5.41%(+4.0%)
Sep 2014
-
5.20%(-11.0%)
Jun 2014
-
5.84%(+2.1%)
Mar 2014
-
5.72%(-4.8%)
Dec 2013
5.92%(-13.7%)
6.01%(-2.0%)
Sep 2013
-
6.13%(-9.1%)
Jun 2013
-
6.74%(-1.7%)
Mar 2013
-
6.86%(+0.4%)
Dec 2012
6.86%(+5176.9%)
6.83%(+810.7%)
Sep 2012
-
0.75%(+33.9%)
Jun 2012
-
0.56%(+93.1%)
Mar 2012
-
0.29%(+123.1%)
Dec 2011
0.13%(-97.5%)
0.13%(-97.6%)
Sep 2011
-
5.49%(-2.7%)
Jun 2011
-
5.64%(+3.3%)
Mar 2011
-
5.46%(+4.6%)
Dec 2010
5.22%(+140.6%)
5.22%(+6.5%)
Sep 2010
-
4.90%(+35.0%)
Jun 2010
-
3.63%(+38.0%)
Mar 2010
-
2.63%(+21.8%)
Dec 2009
2.17%(-71.6%)
2.16%(-9.2%)
Sep 2009
-
2.38%(-42.0%)
Jun 2009
-
4.10%(-34.0%)
Mar 2009
-
6.21%(-17.9%)
Dec 2008
7.65%(-12.8%)
7.56%(-14.5%)
Sep 2008
-
8.84%(+2.2%)
Jun 2008
-
8.65%(+4.3%)
Mar 2008
-
8.29%(-5.4%)
Dec 2007
8.77%(-413.2%)
8.76%(+573.8%)
Sep 2007
-
1.30%(+490.9%)
Jun 2007
-
0.22%(-120.4%)
Mar 2007
-
-1.08%(-60.9%)
Dec 2006
-2.80%(-139.4%)
-2.76%(-192.0%)
Sep 2006
-
3.00%(-24.4%)
Jun 2006
-
3.97%(-27.6%)
Mar 2006
-
5.48%(-20.3%)
Dec 2005
7.10%
6.88%(-12.0%)
DateAnnualQuarterly
Sep 2005
-
7.82%(+19.6%)
Jun 2005
-
6.54%(-6.4%)
Mar 2005
-
6.99%(-5.2%)
Dec 2004
7.59%(-2.9%)
7.37%(-15.5%)
Sep 2004
-
8.72%(-19.6%)
Jun 2004
-
10.84%(+21.9%)
Mar 2004
-
8.89%(-9.3%)
Dec 2003
7.82%(-23.3%)
9.80%(+11.4%)
Sep 2003
-
8.80%(+2.3%)
Jun 2003
-
8.60%(-20.2%)
Mar 2003
-
10.78%(+8.5%)
Dec 2002
10.19%(+7.4%)
9.94%(-5.8%)
Sep 2002
-
10.55%(+0.9%)
Jun 2002
-
10.46%(+1.3%)
Mar 2002
-
10.33%(+7.0%)
Dec 2001
9.49%(+8.6%)
9.65%(+3.9%)
Sep 2001
-
9.29%(+6.4%)
Jun 2001
-
8.73%(+10.2%)
Mar 2001
-
7.92%(-9.2%)
Dec 2000
8.74%(-36.8%)
8.72%(-15.4%)
Sep 2000
-
10.31%(-13.7%)
Jun 2000
-
11.95%(-14.1%)
Mar 2000
-
13.91%(+0.4%)
Dec 1999
13.82%(+33.9%)
13.86%(+4.3%)
Sep 1999
-
13.29%(-4.7%)
Jun 1999
-
13.94%(+5.5%)
Mar 1999
-
13.21%(+26.4%)
Dec 1998
10.32%(-333.5%)
10.45%(-377.9%)
Sep 1998
-
-3.76%(-19.1%)
Jun 1998
-
-4.65%(-12.3%)
Mar 1998
-
-5.30%(+21.8%)
Dec 1997
-4.42%(-131.7%)
-4.35%(-145.9%)
Sep 1997
-
9.48%(+0.9%)
Jun 1997
-
9.40%(-6.8%)
Mar 1997
-
10.09%(-15.6%)
Dec 1996
13.96%(-24.4%)
11.96%(-4.6%)
Sep 1996
-
12.54%(-7.9%)
Jun 1996
-
13.61%(-7.7%)
Mar 1996
-
14.75%(-13.9%)
Dec 1995
18.46%(+37.8%)
17.13%(+7.1%)
Sep 1995
-
15.99%(+6.5%)
Jun 1995
-
15.01%(+11.0%)
Mar 1995
-
13.52%(+0.4%)
Dec 1994
13.40%(-465.1%)
13.47%(+279.4%)
Sep 1994
-
3.55%(+248.0%)
Jun 1994
-
1.02%(-156.7%)
Mar 1994
-
-1.80%(-46.1%)
Dec 1993
-3.67%(-132.5%)
-3.34%(-165.0%)
Sep 1993
-
5.14%(-14.3%)
Jun 1993
-
6.00%(-31.7%)
Mar 1993
-
8.78%(-21.7%)
Dec 1992
11.28%(-32.3%)
11.21%(-10.0%)
Sep 1992
-
12.46%(-12.4%)
Jun 1992
-
14.23%(-8.1%)
Mar 1992
-
15.49%(-5.1%)
Dec 1991
16.67%(-19.8%)
16.33%(-3.4%)
Sep 1991
-
16.90%(-7.1%)
Jun 1991
-
18.19%(-14.8%)
Mar 1991
-
21.35%(+2.5%)
Dec 1990
20.78%(-834.3%)
20.83%(+79.1%)
Sep 1990
-
11.63%(+154.5%)
Jun 1990
-
4.57%(+143.1%)
Mar 1990
-
1.88%(-187.0%)
Dec 1989
-2.83%(-137.1%)
-2.16%(-148.6%)
Sep 1989
-
4.44%(-39.5%)
Jun 1989
-
7.34%(+14.3%)
Mar 1989
-
6.42%(-33.4%)
Dec 1988
7.62%(-51.5%)
9.64%(-2.6%)
Sep 1988
-
9.90%(-9.1%)
Jun 1988
-
10.89%(-8.3%)
Mar 1988
-
11.88%(+9.1%)
Dec 1987
15.71%(-12.5%)
10.89%(-52.8%)
Sep 1987
-
23.08%(+12.5%)
Jun 1987
-
20.51%(+14.3%)
Mar 1987
-
17.95%(+16.7%)
Dec 1986
17.95%
15.38%

FAQ

  • What is the all time high annual ROE for CONMED?
  • What is CONMED quarterly return on equity?
  • What is the all time high quarterly ROE for CONMED?
  • What is CONMED quarterly ROE year-on-year change?

What is the all time high annual ROE for CONMED?

CONMED all-time high annual return on equity is 20.78%

What is CONMED quarterly return on equity?

The current quarterly ROE of CNMD is 15.32%

What is the all time high quarterly ROE for CONMED?

CONMED all-time high quarterly return on equity is 23.08%

What is CONMED quarterly ROE year-on-year change?

Over the past year, CNMD quarterly return on equity has changed by +7.07% (+85.70%)